Literature DB >> 30603764

Short-Term Readmissions After Open, Thoracoscopic, and Robotic Lobectomy for Lung Cancer Based on the Nationwide Readmissions Database.

Katherine L Bailey1, Natalie Merchant1, Young-Ji Seo1, David Elashoff2, Peyman Benharash1,3, Jane Yanagawa4,5.   

Abstract

BACKGROUND: Readmission after surgery is an established surrogate indicator of quality of care. We aimed to compare short-term readmission rates and patient outcomes between open, video-assisted thoracoscopic (VATS), and robotic lobectomies in the Nationwide Readmissions Database (NRD).
METHODS: Adults who underwent open, VATS, or robotic lobectomy for lung cancer from 2010 to 2014 were evaluated. Propensity-matched analysis was used to assess differences in readmission characteristics, GDP-adjusted cost, and mortality.
RESULTS: Of the 129,539 lobectomies for lung cancer, 74,493 (57.5%) were open, 48,185 (37.2%) VATS, and 6861 (5.3%) robotic. Open surgery was associated with significantly higher readmission rate (10.5 vs 9.3%, p < 0.001), mortality (2 vs 1.2%, p < 0.001), index hospitalization cost [$21,846 (16,158-31,034) vs $20,779 (15,619-27,920), p < 0.001], and length of stay [6 (5-9) vs 4 (3-7) days, p < 0.001] compared to minimally invasive surgery. The robotic approach had similar mortality, readmission rate, and length of stay compared to VATS, but higher index cost [$23,870 (18,372-31,300) vs $20,279 (15,275-27,375), p < 0.001] and incidence of pulmonary complication (35.9 vs 31.6%, p < 0.001). The robotic approach was associated with greater direct discharges to home.
CONCLUSIONS: Analysis of the NRD revealed significantly reduced readmission rates, better clinical outcomes, and lower cost in the minimally invasive approach compared to open surgery. Although VATS and robotic surgery had similar readmission and mortality rates, VATS is associated with significantly reduced risk of short-term complications and lower cost.

Entities:  

Mesh:

Year:  2019        PMID: 30603764     DOI: 10.1007/s00268-018-04900-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  3 in total

1.  Determining the most important factors in hospital readmission following surgery for lung cancer.

Authors:  Masayuki Nakao; Junji Ichinose; Yosuke Matsuura; Sakae Okumura; Mingyon Mun
Journal:  Ann Transl Med       Date:  2019-12

2.  Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States.

Authors:  Raees Tonse; Alexandra Townsend; Muni Rubens; Vitaly Siomin; Michael W McDermott; Martin C Tom; Matthew D Hall; Yazmin Odia; Manmeet S Ahluwalia; Minesh P Mehta; Rupesh Kotecha
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

Review 3.  Overview of the outcomes of robotic segmentectomy and lobectomy.

Authors:  Giulia Veronesi; Pierluigi Novellis; Gianluca Perroni
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 3.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.